Genitourinary Cancers Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
SECTION HEADS
Section Topics
- » Bladder cancer: clinical trials
- » Bladder cancer: surgery
- » Bladder cancer: translational research/prevention/early detection
- » Penile cancer: prevention
- » Penile cancer: surgery
- » Penile cancer: translational research/new treatments
- » Prostate cancer: clinical trials
- » Prostate cancer: prevention
- » Prostate cancer: surgery
- » Prostate cancer: translational research/new treatments
- » Renal cell cancer: clinical trials
- » Renal cell cancer: surgery
- » Testicular cancer: prevention
- » Testicular cancer: surgery
- » Testicular cancer: translational research/new treatments
LATEST RECOMMENDATION
Jean-Jacques Wyndaele, University Antwerp and Antwerp University Hospital, Belgium. F1000 Urology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
2 Recommendations, most recent by
Jean Pierre Droz and Helen Boyle, Center Léon-Bérard, France. F1000 Oncology
- Clinical Trial
- Clinical Trial: RCT
- Controversial
- Good for Teaching
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

